12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Company News  |  Other News

Roche, Medicines Patent Pool infectious news

Roche and the Medicines Patent Pool signed a five-year supply deal under which the pharma will provide Valcyte valganciclovir to treat cytomegalovirus (CMV) in HIV-infected patients to the pool for a price that is up to 90% cheaper than the current market...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >